Reduced Let-7f in Bone Marrow-Derived Mesenchymal Stem Cells Triggers Treg/Th17 Imbalance in Patients With Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) patients exist an imbalance between regulatory T (Treg) and T helper 17 cells (Th17), which might be contributed by defective immune regulation of bone marrow derived mesenchymal stem cells (BM-MSCs) from SLE patients. Our microRNA array analysis showed markedly do...

Full description

Bibliographic Details
Main Authors: Linyu Geng, Xiaojun Tang, Shiying Wang, Yue Sun, Dandan Wang, Betty P. Tsao, Xuebing Feng, Lingyun Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-02-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.00233/full
_version_ 1818040191532662784
author Linyu Geng
Linyu Geng
Xiaojun Tang
Shiying Wang
Yue Sun
Dandan Wang
Betty P. Tsao
Xuebing Feng
Lingyun Sun
author_facet Linyu Geng
Linyu Geng
Xiaojun Tang
Shiying Wang
Yue Sun
Dandan Wang
Betty P. Tsao
Xuebing Feng
Lingyun Sun
author_sort Linyu Geng
collection DOAJ
description Systemic lupus erythematosus (SLE) patients exist an imbalance between regulatory T (Treg) and T helper 17 cells (Th17), which might be contributed by defective immune regulation of bone marrow derived mesenchymal stem cells (BM-MSCs) from SLE patients. Our microRNA array analysis showed markedly down-regulated expression levels of microRNA let-7f in BM-MSCs from SLE patients compared to those from normal controls (NOR). To explore the role of let-7f in the disease pathogenesis, we showed that expression levels of let-7f in SLE BM-MSCs were negatively associated with SLE disease activity, and the predicted let-7 family targeted gene expression of interlukin-6 (IL-6) was significantly higher in BM-MSCs from SLE patients compared to normal controls (NOR). Transient transfection of BM-MSCs with let-7f mimics or inhibitors showed reduced levels of let-7f impaired the proliferation rate of BM-MSCs, BM-MSC-mediated downregulation of Th17 cells and upregulation of Treg cells, increased the apoptosis rate of BM-MSCs through targeting IL-6 and activating signal transducers and activators of transcription-3 (STAT3) pathway, but had no significant effect on the differentiation of Th1 and Th2. Our findings showed a key role of let-7f in the imbalance of Treg/Th17 mediated by SLE BM-MSCs, suggesting the potential of manipulating let-7f expression in BM-MSCs for treating SLE patients.
first_indexed 2024-12-10T08:10:36Z
format Article
id doaj.art-e6b97d576b68470fa3f9faa1a72cce7b
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-10T08:10:36Z
publishDate 2020-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-e6b97d576b68470fa3f9faa1a72cce7b2022-12-22T01:56:35ZengFrontiers Media S.A.Frontiers in Immunology1664-32242020-02-011110.3389/fimmu.2020.00233477718Reduced Let-7f in Bone Marrow-Derived Mesenchymal Stem Cells Triggers Treg/Th17 Imbalance in Patients With Systemic Lupus ErythematosusLinyu Geng0Linyu Geng1Xiaojun Tang2Shiying Wang3Yue Sun4Dandan Wang5Betty P. Tsao6Xuebing Feng7Lingyun Sun8Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, ChinaDivision of Rheumatology & Immunology, Medical University of South Carolina, Charleston, SC, United StatesDepartment of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, ChinaDepartment of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, ChinaDepartment of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, ChinaDepartment of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, ChinaDivision of Rheumatology & Immunology, Medical University of South Carolina, Charleston, SC, United StatesDepartment of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, ChinaDepartment of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, ChinaSystemic lupus erythematosus (SLE) patients exist an imbalance between regulatory T (Treg) and T helper 17 cells (Th17), which might be contributed by defective immune regulation of bone marrow derived mesenchymal stem cells (BM-MSCs) from SLE patients. Our microRNA array analysis showed markedly down-regulated expression levels of microRNA let-7f in BM-MSCs from SLE patients compared to those from normal controls (NOR). To explore the role of let-7f in the disease pathogenesis, we showed that expression levels of let-7f in SLE BM-MSCs were negatively associated with SLE disease activity, and the predicted let-7 family targeted gene expression of interlukin-6 (IL-6) was significantly higher in BM-MSCs from SLE patients compared to normal controls (NOR). Transient transfection of BM-MSCs with let-7f mimics or inhibitors showed reduced levels of let-7f impaired the proliferation rate of BM-MSCs, BM-MSC-mediated downregulation of Th17 cells and upregulation of Treg cells, increased the apoptosis rate of BM-MSCs through targeting IL-6 and activating signal transducers and activators of transcription-3 (STAT3) pathway, but had no significant effect on the differentiation of Th1 and Th2. Our findings showed a key role of let-7f in the imbalance of Treg/Th17 mediated by SLE BM-MSCs, suggesting the potential of manipulating let-7f expression in BM-MSCs for treating SLE patients.https://www.frontiersin.org/article/10.3389/fimmu.2020.00233/fulllet-7f miRNAsystemic lupus erythematosusbone marrow derived mesenchymal stem cellinterlukin 6regulatory T cell (Treg)T help cell 17 (Th17)
spellingShingle Linyu Geng
Linyu Geng
Xiaojun Tang
Shiying Wang
Yue Sun
Dandan Wang
Betty P. Tsao
Xuebing Feng
Lingyun Sun
Reduced Let-7f in Bone Marrow-Derived Mesenchymal Stem Cells Triggers Treg/Th17 Imbalance in Patients With Systemic Lupus Erythematosus
Frontiers in Immunology
let-7f miRNA
systemic lupus erythematosus
bone marrow derived mesenchymal stem cell
interlukin 6
regulatory T cell (Treg)
T help cell 17 (Th17)
title Reduced Let-7f in Bone Marrow-Derived Mesenchymal Stem Cells Triggers Treg/Th17 Imbalance in Patients With Systemic Lupus Erythematosus
title_full Reduced Let-7f in Bone Marrow-Derived Mesenchymal Stem Cells Triggers Treg/Th17 Imbalance in Patients With Systemic Lupus Erythematosus
title_fullStr Reduced Let-7f in Bone Marrow-Derived Mesenchymal Stem Cells Triggers Treg/Th17 Imbalance in Patients With Systemic Lupus Erythematosus
title_full_unstemmed Reduced Let-7f in Bone Marrow-Derived Mesenchymal Stem Cells Triggers Treg/Th17 Imbalance in Patients With Systemic Lupus Erythematosus
title_short Reduced Let-7f in Bone Marrow-Derived Mesenchymal Stem Cells Triggers Treg/Th17 Imbalance in Patients With Systemic Lupus Erythematosus
title_sort reduced let 7f in bone marrow derived mesenchymal stem cells triggers treg th17 imbalance in patients with systemic lupus erythematosus
topic let-7f miRNA
systemic lupus erythematosus
bone marrow derived mesenchymal stem cell
interlukin 6
regulatory T cell (Treg)
T help cell 17 (Th17)
url https://www.frontiersin.org/article/10.3389/fimmu.2020.00233/full
work_keys_str_mv AT linyugeng reducedlet7finbonemarrowderivedmesenchymalstemcellstriggerstregth17imbalanceinpatientswithsystemiclupuserythematosus
AT linyugeng reducedlet7finbonemarrowderivedmesenchymalstemcellstriggerstregth17imbalanceinpatientswithsystemiclupuserythematosus
AT xiaojuntang reducedlet7finbonemarrowderivedmesenchymalstemcellstriggerstregth17imbalanceinpatientswithsystemiclupuserythematosus
AT shiyingwang reducedlet7finbonemarrowderivedmesenchymalstemcellstriggerstregth17imbalanceinpatientswithsystemiclupuserythematosus
AT yuesun reducedlet7finbonemarrowderivedmesenchymalstemcellstriggerstregth17imbalanceinpatientswithsystemiclupuserythematosus
AT dandanwang reducedlet7finbonemarrowderivedmesenchymalstemcellstriggerstregth17imbalanceinpatientswithsystemiclupuserythematosus
AT bettyptsao reducedlet7finbonemarrowderivedmesenchymalstemcellstriggerstregth17imbalanceinpatientswithsystemiclupuserythematosus
AT xuebingfeng reducedlet7finbonemarrowderivedmesenchymalstemcellstriggerstregth17imbalanceinpatientswithsystemiclupuserythematosus
AT lingyunsun reducedlet7finbonemarrowderivedmesenchymalstemcellstriggerstregth17imbalanceinpatientswithsystemiclupuserythematosus